News Focus
News Focus
Replies to #909 on Biotech Values
icon url

DewDiligence

01/21/04 11:00 AM

#910 RE: swampboots #909

I certainly can’t complain –made almost 30% on OXGN in less than two months.

I will remain on the sidelines until management fully addresses the cardiac-toxicity issue. I expect some pointed questions about this at OXGN’s CC in mid February.

icon url

DewDiligence

01/21/04 11:35 AM

#911 RE: swampboots #909

FWIW: I just sold short IMDC.